Where can you purchase fabrics fit for a queen in Perth? Fabulous fabrics of course! And this isn’t just a figure of speech in this case, with the King, Queen and Princess of Thailand stopping by to ...

Much in the same way that many of us have a favourite fail-safe paint colour to which we frequently turn, a familiar fabric can provide a huge amount of relief when decorating a space. As much as we ...

Rebecca Sramkova advanced to her first quarterfinal of the season after defeating Brazil's Beatriz Haddad Maia in straight sets in the Round of 16 at the Merida Open Akron. Why not watch this next… ...

Credit: Dalin Ou via Getty Images. US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing antibodies in autoimmune diseases and ...

Speaking at the 24th Commonwealth Law Conference, 2025 in Malta, Justice Surya Kant said the Supreme Court of India “has consistently been at the forefront of shaping the moral and ethical fabric of ...

Merida Biosciences, a startup formed by venture capital firm Third Rock Ventures, emerged from stealth Tuesday, revealing $121 million in financing and a lead program for a common autoimmune ...

Series A financing co-led by Bain Capital Life Sciences, BVF Partners and Third Rock Ventures Merida Biosciences, a biotechnology company pioneering a new class of precision therapeutics designed ...

Merida Therapeutics was seeded by Third Rock back in 2022, when the biotech’s co-founder and chief scientific officer Dario Gutierrez, Ph.D., was entrepreneur-in-residence at the VC firm.

A scrap­py team of drug de­vel­op­ers has come to­geth­er to cre­ate new med­i­cines for pa­tients with au­toim­mune dis­eases and al­ler­gies. They’re go­ing af­ter the ...

April 08, 2025--(BUSINESS WIRE)--Merida Biosciences, a biotechnology company pioneering a new class of precision therapeutics designed to selectively and durably eliminate the pathogenic antibody ...

A new biotech, Merida Biosciences, has launched with $121 million in the bank to advance a new class of precision treatments for autoimmune and allergic diseases. Merida’s therapies are “antibody-like ...